MP5 is a GMP contract manufacturer of sterile pharmaceutical and biotech products for use in Phase I/II clinical trials.
MP5 is dedicated to the development and the manufacture of cytotoxic/highly potent drugs as well as biologics for preclinical development and clinical trials.
MP5 has a proven track record of formulation, fill and finish of targeted cytotoxic therapies for oncology clinical trials. This strong track record of experience includes developing non betalactamin antibiotics, enzyme inhibitors, cytotoxics, highly potent drugs, peptides and proteins.
MP5 is registered by the French Health Agency (AFSSAPS) for the manufacture of clinical trial material according to the EU-GMP Annex 13. MP5’s GMP Authorization Number is M09/435. MP5 also complies with US FDA GMPs.
MP5 provides a strong project management process and easy to work with staff that has more than 150 years of experience to deliver your product quickly and safely, all while adhering to the highest quality standards.
MP5 is a subsidiary of Creapharm, one of the leading clinical supply services companies in Europe. MP5 will help you bring your clinical trial materials to any investigation center across Europe as well as the world and meet your most demanding supply chain requirements.
